Pedro Rocha

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study.

Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 25, 2026

ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancer.

ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 17, 2026

ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancer.

ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 17, 2026

Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

Journal: Investigational new drugs

Published: March 12, 2026

Peripheral immune cell subsets as potential predictors of benefit from immune checkpoint blockade therapy in small cell lung cancer.

Peripheral immune cell subsets as potential predictors of benefit from immune checkpoint blockade therapy in small cell lung cancer.

Journal: Frontiers in immunology

Published: February 02, 2026

Brief report: Artificial intelligence meets small cell lung cancer-integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC.

Brief report: Artificial intelligence meets small cell lung cancer-integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC.

Journal: Frontiers in artificial intelligence

Published: December 12, 2025

Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment.

Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment.

Journal: Genome medicine

Published: November 07, 2025

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

Journal: Cancers

Published: October 24, 2025

YAP1 Defines an Emergent, Plastic Population of Relapsed SCLC.

YAP1 Defines an Emergent, Plastic Population of Relapsed SCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: October 21, 2025

Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial.

Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 14, 2025

Insights on Oligometastatic Non-Small-Cell Lung Cancer.

Insights on Oligometastatic Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: June 19, 2025

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.

Journal: The New England journal of medicine

Published: June 02, 2025

Showing 1-12 of 47

Last Updated: 09/26/2026